CJ Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,130	10,339	8,309	64,095	49,324	62,060
Short-Term Investments	42,000	40,500	67,000	-	-	18,020
Cash & Short-Term Investments	44,130	50,839	75,309	64,095	49,324	80,080
Cash Growth	-32.13%	-32.49%	17.50%	29.95%	-38.41%	103.89%
Accounts Receivable	230.35	418.8	72.57	160.91	303.82	233.62
Other Receivables	740.19	432.46	623.2	178.66	523.06	474.16
Receivables	970.53	851.26	695.77	339.57	826.88	707.78
Inventory	258.36	185.13	128.75	157.82	76.16	145.83
Prepaid Expenses	328.38	218.73	294.56	355.71	446.57	259.18
Other Current Assets	406.43	384.56	333.6	262.22	258.72	362.03
Total Current Assets	46,094	52,478	76,762	65,210	50,932	81,555
Property, Plant & Equipment	5,851	6,637	8,907	12,707	14,364	9,856
Long-Term Investments	2	2	2	2	2	0
Other Intangible Assets	11,770	11,778	12,499	12,397	1,016	114.13
Other Long-Term Assets	1,373	1,442	1,439	811.16	25,075	24,830
Total Assets	65,090	72,337	99,610	91,128	91,389	116,355
Accounts Payable	300.64	378.32	220.83	122.82	336.65	287.75
Accrued Expenses	896.76	2,229	3,234	3,966	3,996	140.94
Short-Term Debt	7,497	6,984	6,365	3,971	23,588	18,441
Current Portion of Leases	1,890	1,932	1,824	1,869	1,547	1,361
Other Current Liabilities	2,449	3,035	6,882	4,793	5,511	3,606
Total Current Liabilities	13,034	14,558	18,525	14,722	34,979	23,836
Long-Term Leases	1,225	1,495	1,162	2,692	3,831	4,088
Pension & Post-Retirement Benefits	-	-	-	65.47	-	-
Other Long-Term Liabilities	2,720	2,645	2,166	2,152	2,924	577.4
Total Liabilities	16,979	18,698	21,853	19,633	41,734	28,502
Common Stock	6,533	6,533	6,533	4,556	2,939	2,937
Additional Paid-In Capital	189,419	189,419	189,419	151,426	108,066	112,186
Retained Earnings	-148,459	-143,313	-119,067	-85,951	-62,738	-28,035
Comprehensive Income & Other	618.65	1,001	872.04	1,465	1,389	765.25
Shareholders' Equity	48,111	53,639	77,757	71,496	49,655	87,853
Total Liabilities & Equity	65,090	72,337	99,610	91,128	91,389	116,355
Total Debt	10,612	10,411	9,351	8,533	28,966	23,891
Net Cash (Debt)	33,518	40,427	65,958	55,562	20,357	56,190
Net Cash Growth	-40.13%	-38.71%	18.71%	172.93%	-63.77%	1501.15%
Net Cash Per Share	2565.50	3094.21	7112.48	7843.75	3463.50	13214.21
Filing Date Shares Outstanding	13.07	13.07	13.07	9.11	5.88	5.87
Total Common Shares Outstanding	13.07	13.07	13.07	9.11	5.88	5.87
Working Capital	33,060	37,920	58,236	50,488	15,953	57,718
Book Value Per Share	3682.33	4105.42	5951.30	7845.89	8446.71	14957.10
Tangible Book Value	36,341	41,861	65,257	59,098	48,640	87,739
Tangible Book Value Per Share	2781.47	3203.95	4994.63	6485.40	8273.89	14937.67
Machinery	-	13,053	14,051	13,686	10,339	4,411
Construction In Progress	-	-	-	-	521.7	-